MARTINELLI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 4.814
EU - Europa 2.219
AS - Asia 1.814
SA - Sud America 249
Continente sconosciuto - Info sul continente non disponibili 77
AF - Africa 47
OC - Oceania 17
Totale 9.237
Nazione #
US - Stati Uniti d'America 4.714
GB - Regno Unito 700
SG - Singapore 565
IT - Italia 534
CN - Cina 424
HK - Hong Kong 245
VN - Vietnam 245
DE - Germania 225
SE - Svezia 210
BR - Brasile 170
FI - Finlandia 113
RU - Federazione Russa 102
BD - Bangladesh 81
UA - Ucraina 79
FR - Francia 67
TR - Turchia 59
CA - Canada 51
ID - Indonesia 33
IN - India 31
KR - Corea 29
BG - Bulgaria 27
IE - Irlanda 27
NL - Olanda 25
BE - Belgio 19
AU - Australia 17
MX - Messico 17
PL - Polonia 17
AR - Argentina 16
CZ - Repubblica Ceca 16
ES - Italia 16
CL - Cile 13
IQ - Iraq 13
JP - Giappone 13
ZA - Sudafrica 13
AE - Emirati Arabi Uniti 12
UZ - Uzbekistan 12
VE - Venezuela 11
CO - Colombia 10
MA - Marocco 10
PE - Perù 10
PH - Filippine 9
PK - Pakistan 9
RO - Romania 9
JM - Giamaica 7
EC - Ecuador 6
KE - Kenya 6
PY - Paraguay 6
AZ - Azerbaigian 5
DZ - Algeria 5
LT - Lituania 5
AT - Austria 4
BO - Bolivia 4
BZ - Belize 4
CH - Svizzera 4
CR - Costa Rica 4
JO - Giordania 4
MY - Malesia 4
SA - Arabia Saudita 4
DK - Danimarca 3
ET - Etiopia 3
HN - Honduras 3
KZ - Kazakistan 3
SN - Senegal 3
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GR - Grecia 2
GT - Guatemala 2
GY - Guiana 2
HR - Croazia 2
KG - Kirghizistan 2
MD - Moldavia 2
MK - Macedonia 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BS - Bahamas 1
EG - Egitto 1
GA - Gabon 1
GD - Grenada 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KW - Kuwait 1
LV - Lettonia 1
NP - Nepal 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 9.158
Città #
Southend 522
Ashburn 513
Fairfield 475
Santa Clara 352
Singapore 349
Woodbridge 288
Houston 243
Hong Kong 237
Chandler 236
San Jose 204
Seattle 194
Ann Arbor 176
Cambridge 172
Wilmington 148
Dearborn 123
Nyköping 123
Jacksonville 120
Council Bluffs 110
Modena 95
Hefei 87
Los Angeles 84
Beijing 82
Helsinki 82
New York 79
London 76
Ho Chi Minh City 70
Milan 60
Hanoi 56
Chicago 53
Munich 48
The Dalles 47
Fremont 40
Salt Lake City 34
Bologna 33
Izmir 29
Princeton 28
Columbus 27
Dublin 27
Lauterbourg 27
Seoul 27
Sofia 27
Eugene 26
Moscow 26
Rome 26
Bremen 25
Buffalo 25
San Diego 25
Jakarta 24
Dallas 21
Brussels 19
Tampa 17
Atlanta 16
Warsaw 16
Frankfurt am Main 15
Orem 15
São Paulo 15
Boardman 12
Dong Ket 12
Haiphong 12
Montreal 12
Reggio Emilia 12
Shanghai 12
Toronto 12
Brno 11
Phoenix 11
Denver 10
Bari 9
Da Nang 9
Des Moines 9
Miami 9
Redwood City 9
Tashkent 9
Amsterdam 8
Brooklyn 8
Tokyo 8
Turku 8
Can Tho 7
Elk Grove Village 7
Jinan 7
Lancaster 7
Naples 7
North Bergen 7
Poplar 7
Sydney 7
Baghdad 6
Brasília 6
Castelnuovo Rangone 6
Falls Church 6
Hillsboro 6
Nairobi 6
Nuremberg 6
San Francisco 6
Sterling 6
Venice 6
Bogotá 5
Caracas 5
Cascina 5
Changsha 5
Chennai 5
Chiclayo 5
Totale 6.462
Nome #
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 608
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor 445
SVILUPPO DI IPOGAMMAGLOBULINEMIA IN PAZIENTI TRATTATI CON IMATINIB PER LEUCEMIA MIELOIDE CRONICA O TUMORI STROMALI GASTROINTESTINALI 426
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 397
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 378
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 367
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 356
Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with Flt3 mutational status 346
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 342
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 333
Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. 332
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 324
Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis 318
Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status 316
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia 313
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 307
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 305
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 302
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 301
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 287
INTERACTION BETWEEN ENDOTHELIUM AND CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS RESCUES FROM APOPTOSIS AND MODULATES GENE EXPRESSION PROFILE OF LEUKEMIC CELLS 284
Immunoglobulin mutational status detected through single-round amplification of partial VH region, represents a good prognostic marker for the clinical outcome in chronic lymphocytic leukemia 284
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 276
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms 273
Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms 254
Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia via Kynurenine/Aryl Hydrocarbon Receptor-Mediated MCL1 Modulation 254
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone. 252
Efficacy of imatinib mesylate as maintenance therapy in adults with acute lymphoblastic leukemia in first complete remission 196
Optical genome mapping reveals multiple apoptotic and cell-cycle pathway aberrations in B-cell prolymphocytic leukemia: a report of three cases 39
OPTICAL GENOME MAPPING IDENTIFIES MULTIPLE STRUCTURAL VARIATION AND CATASTROPHIC REARRANGEMENTS IN B-CELL PROLYMPHOCYTIC LEUKEMIA 22
Totale 9.237
Categoria #
all - tutte 32.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.419


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022460 0 0 51 25 6 56 23 25 55 45 119 55
2022/2023708 72 90 55 64 94 95 8 80 81 5 28 36
2023/2024488 17 22 28 54 74 46 51 64 14 24 43 51
2024/20251.484 54 41 19 113 236 214 125 89 149 67 165 212
2025/20262.623 203 90 179 259 406 175 372 122 261 256 154 146
2026/2027264 63 162 39 0 0 0 0 0 0 0 0 0
Totale 9.237